PTAB challenges

Proceedings overview

One AIA trial proceeding has been filed against US patent 10996417. This proceeding was denied institution, indicating that the patent owner prevailed at the institution stage. This gives a defendant a somewhat strengthened defensive posture, as the patent has withstood a challenge and all claims remain intact and untested by a final written decision.

IPR2025-01119 — Belden Inc. et al. v. Commscope Technologies LLC

• Type: Inter Partes Review
• Filed: 2025-06-10
• Status: Institution Denied. The PTAB declined to institute the IPR.
• Judge panel: Information not publicly available at this level of detail without direct PTAB E2E portal access.
• Petition grounds: Specific claims and prior art asserted in the petition are not publicly detailed in the provided data. Typically, IPR petitions challenge claims under 35 U.S.C. §§ 102 and/or 103.
• Institution decision: Denied on 2025-12-23. The panel's reasoning for denial is not specified in the provided data. Institution denials can be based on various factors, including failing to show a reasonable likelihood of prevailing on at least one claim, discretionary denials (e.g., Fintiv factors), or deficiencies in the petition itself.
• Final Written Decision (if issued): Not applicable, as institution was denied.
• Settlement / termination: Not applicable, as institution was denied.
• Appeal: Not applicable, as institution was denied.
• Defensive value: The denial of institution means all claims of US10996417 remain patentable over the prior art asserted in this petition, as no inter partes review was initiated. This outcome suggests that the patent owner successfully argued against the merits or procedural aspects of the petition, making an IPR-based defense using the same grounds by this specific petitioner more difficult in the future.

Strategic summary

All claims of US10996417 remain SUSTAINED and UNTESTED by a Final Written Decision at the PTAB. IPR2025-01119 was denied institution, meaning the PTAB did not proceed to a full review of the challenged claims. Consequently, there are no claims that have been canceled or invalidated through an AIA trial proceeding.

Regarding the estoppel landscape, since IPR2025-01119 was denied institution, 35 U.S.C. § 315(e)(2) estoppel, which bars petitioners and their privies from raising grounds raised or reasonably could have raised, generally does not apply. This is because estoppel typically only attaches upon a final written decision. Therefore, the prior-art grounds raised in IPR2025-01119 would likely still be available to other potential petitioners (who are not in privity with Belden Inc. et al.) or even potentially to Belden Inc. et al. in district court if the denial was not on the merits or if new arguments/evidence were presented. However, the specific reasoning for the denial would need to be reviewed to fully assess any potential preclusive effects. There are no clear pattern signals of multiple IPRs by the same petitioner on this specific patent, nor aggressive PTAB appeals by the patent owner, given only one proceeding was filed and it was denied institution. The Google Patents page for US10996417 does show "Unified Patents Litigation Data" for a Delaware District Court case and an IPR (IPR2025-01119), noting Unified Patents as the petitioner in the IPR data provided by Google, though the structured data provided in the prompt explicitly names "Belden Inc. et al." as the petitioner. For this analysis, the structured "PTAB proceedings on file" provided in the prompt is the canonical source for petitioner information for the IPR.

Recommended next steps

For a defendant currently facing assertion of US10996417, the primary takeaway is that all claims remain intact as a result of the IPR institution denial. There is no Final Written Decision to link to for invalidated claims. To understand the precise implications of the institution denial for IPR2025-01119, it would be crucial to obtain and review the Board's decision denying institution. This decision would clarify the specific grounds asserted by Belden Inc. et al. and the PTAB's reasoning for declining review. This insight can inform whether a subsequent IPR petition might be viable using different prior art, different arguments, or if the denial was based on discretionary factors that could be avoided.

Since no active proceedings are pending, there are no upcoming trial-stage milestones. The absence of additional PTAB activity, particularly subsequent to this denial, could be seen as a signal, but a thorough prior art search would be necessary to determine if other viable IPR grounds exist.